Last checked at 7 Dec 2020 12:00
Ap19
FORM 8.3 - Amendment to Purchase & Sales
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE
1. KEY INFORMATION
| Name of person dealing (Note 1) | Barclays PLC. | |
| Company dealt in | WILLIS TOWERS WATSON PLC | |
| Class of relevant security to which the | ORD | |
| dealings being disclosed relate (Note 2) | ||
| Date of dealing | 01 December 2020 |
2. INTERESTS AND SHORT POSITIONS
(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)
| Class of relevant security: | ORD | ||||
| Long | Short | ||||
Number | (%) | Number | (%) | ||
(1) | Relevant securities |
|
|
|
|
3,040,214 | 2.36% | 609,448 | 0.47% | ||
|
|
|
| ||
(2) | Derivatives (other than options): |
|
|
|
|
285,019 | 0.22% | 739,005 | 0.57% | ||
|
|
|
| ||
(3) | Options and agreements to |
|
|
|
|
| purchase/sell: | 0 | 0.00% | 0 | 0.00% | |
|
|
|
| ||
| TOTAL: |
|
|
|
| |
3,325,233 | 2.58% | 1,348,453 | 1.05% | ||
|
|
|
| ||
(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)
Class of relevant security: | Long | Short | ||||
| Number |
| (%) | Number |
| (%) |
(1) Relevant securities |
|
| ||||
(2) Derivatives (other than options) |
|
| ||||
(3) Options and agreements to purchase/sell |
|
| ||||
Total |
|
| ||||
| ||||||
Ap20
1. DEALINGS (Note 4)
(a) Purchases and sales
| Purchase/sale | Number of relevant securities | Price per unit |
| Purchase | 1 | 212.6600 USD |
| Purchase | 7 | 213.6621 USD |
| Purchase | 10 | 213.4910 USD |
| Purchase | 13 | 213.8000 USD |
| Purchase | 16 | 213.3828 USD |
| Purchase | 16 | 213.0900 USD |
| Purchase | 19 | 213.1831 USD |
| Purchase | 20 | 213.0662 USD |
| Purchase | 20 | 212.9000 USD |
| Purchase | 22 | 213.0977 USD |
| Purchase | 24 | 213.0416 USD |
| Purchase | 27 | 213.1224 USD |
| Purchase | 31 | 213.1596 USD |
| Purchase | 37 | 213.2294 USD |
| Purchase | 45 | 213.0088 USD |
| Purchase | 49 | 212.9632 USD |
| Purchase | 100 | 213.2200 USD |
| Purchase | 261 | 213.6066 USD |
| Purchase | 267 | 212.9698 USD |
| Purchase | 291 | 213.9262 USD |
| Purchase | 558 | 214.1332 USD |
| Purchase | 1,171 | 213.6508 USD |
| Purchase | 2,920 | 213.1630 USD |
| Purchase | 4,247 | 214.0788 USD |
| Purchase | 5,063 | 214.0892 USD |
| Purchase | 5,409 | 212.8807 USD |
| Purchase | 5,667 | 212.9131 USD |
| Purchase | 16,923 | 213.2208 USD |
| Purchase | 17,295 | 214.0900 USD |
| Sale | 1 | 211.4000 USD |
| Sale | 7 | 212.9221 USD |
| Sale | 9 | 212.6322 USD |
| Sale | 17 | 212.8458 USD |
| Sale | 20 | 212.9000 USD |
| Sale | 24 | 212.8700 USD |
| Sale | 30 | 213.4100 USD |
| Sale | 43 | 213.3000 USD |
| Sale | 45 | 213.7366 USD |
| Sale | 65 | 213.6800 USD |
| Sale | 90 | 213.4850 USD |
| Sale | 100 | 212.8000 USD |
| Sale | 101 | 213.2659 USD |
| Sale | 105 | 213.5357 USD |
| Sale | 150 | 213.6670 USD |
| Sale | 165 | 213.0772 USD |
| Sale | 165 | 213.5545 USD |
| Sale | 178 | 213.3687 USD |
| Sale | 257 | 214.0802 USD |
| Sale | 328 | 213.9153 USD |
| Sale | 473 | 213.0778 USD |
| Sale | 665 | 212.9584 USD |
| Sale | 700 | 213.0531 USD |
| Sale | 1,385 | 213.3111 USD |
| Sale | 2,863 | 213.1576 USD |
| Sale | 4,285 | 212.7858 USD |
| Sale | 4,505 | 214.0261 USD |
| Sale | 4,900 | 214.0849 USD |
| Sale | 4,948 | 213.4467 USD |
| Sale | 5,581 | 212.9096 USD |
| Sale | 10,879 | 213.1986 USD |
| Sale | 15,567 | 214.0900 USD |
(b) Derivatives transactions (other than options transactions)
Product name, e.g. CFD | Nature of transaction (Note 6) | Number of relevant securities (Note 7) | Price per unit (Note 5) |
|
|
|
|
(c) Options transactions in respect of existing relevant securities
(i) Writing, selling, purchasing or varying
Product name, e.g. call option | Writing, selling, purchasing, varying etc. | Number of securities to which the option relates (Note 7) | Exercise price | Type, e.g. American, European etc. | Expiry date | Option money paid/received per unit (Note 5) |
|
|
|
|
|
|
|
(ii) Exercising
Product name, e.g. call option | Number of securities | Exercise price per unit (Note 5) |
|
|
|
(d) Other dealings (including transactions in respect of new securities) (Note 4)
Nature of transaction (Note 8) | Details | Price per unit (if applicable) (Note 5) |
|
|
|
Ap21
2. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives
Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.
None
| Is a Supplemental Form 8 (Open Positions) attached? | NO |
| Date of disclosure: | 7 Dec 2020 |
| Contact name: | Large Holdings Regulatory Operations |
| Telephone number: | 020 3134 7213 |
| If a connected EFM, name of offeree/offeror with which connected | |
| If a connected EFM, state nature of connection |
View source version on businesswire.com: https://www.businesswire.com/news/home/20201207005454/en/
Copyright Business Wire 2020